Schedule 5 to the Principal Order is amended as follows:

(a) by omitting item 5006 and substituting the following:

5006.	Alkaline salts, being the carbonate, silicate or phosphate salts of sodium or potassium, alone or in any combination –
	(a) in solid orthodontic device cleaning preparations, the pH of which as an in-use aqueous solution is more than 11.5; or
	(b) in solid automatic dishwashing preparations the pH of which, in a 500 g/l aqueous solution or mixture is more than 11.5; or
	(c) in other solid preparations, the pH of which in a 10g/l aqueous solution is more than 11.5; or
	(d) in liquid or semisolid preparations, the pH of which is more than 11.5.

(b) by inserting after item 5023 the following:

5023S.

Benzofenap.

(c) by omitting item 5044 and substituting the following:

5044.	Chlortetracycline in preparations –
	(a) for topical application to animals for ocular use only; or
	(b) containing not more than 100 000 international units of chlortetracycline in each dose, for intramammary infusion in animals; or
	(c) containing 40% or less of chlortetracycline, when packed and labelled for the treatment of ornamental caged birds or ornamental fish only.

(d) by omitting item 5149 and substituting the following:

5149.

Imazapic except in preparations containing 25% or less of imazapic.

(e) by inserting after item 5205 the following:

5205M.	Nonoxinol 9 in preparations containing 25% of nonoxinol 9 except –
	(a) when labelled with the statements –
	(i) Irritant; and
	(ii) Avoid contact with eyes; or
	(b) in preparations containing 12.5% or less of nonoxinol 9; or
	(c) in preparations for human use.

(f) by omitting item 5216 and substituting the following:

5216.	Oxytetracycline in preparations –
	(a) for topical application to animals for ocular use only; or
	(b) containing not more than 100 000 international units of oxytetracycline in each dose, for intramammary infusion in animals; or
	(c) containing 40% or less of oxytetracycline, when packed and labelled for the treatment of ornamental caged birds or ornamental fish only.

(g) by omitting item 5229 and substituting the following:

5229.	Phosphoric acid (excluding its salts and derivatives) in preparations containing 35% or less of phosphoric acid (H 3 PO 4 ) except –
	(a) in preparations containing 15% or less of phosphoric acid (H 3 PO 4 ); or
	(b) in solid or semi-solid preparations; or
	(c) in professional dental kits.

(h) by inserting after item 5235 the following:

5235M.	Potassium peroxomosulfate triple salt in preparations containing 5% or less of potassium peroxomosulfate triple salt as –
	(a) solid preparations the pH of which in a 10 g/l aqueous solution is less than 2.5; or
	(b) liquid or semi-solid preparations the pH of which is less than 2.5.

(i) by inserting after item 5236 the following:

5236M.

Sodium percarbonate (CAS No. 15630-89-4) in preparations containing 35% or less of sodium percarbonate except in preparations containing 15% or less of sodium percarbonate.

(j) by omitting item 5275 and substituting the following:

5275.

Symphytum spp. (comfrey) for dermal use.

(k) by omitting item 5286 and substituting the following:

5286.	Tetracycline in preparations –
	(a) for topical application to animals for ocular use only; or
	(b) containing not more than 100 000 international units of tetracycline in each dose, for intramammary infusion in animals; or
	(c) containing 40% or less of tetracycline, when packed and labelled for the treatment of ornamental caged birds or ornamental fish only.